These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3136022)

  • 1. On the structure of polymeric IgM.
    Davis AC; Roux KH; Shulman MJ
    Eur J Immunol; 1988 Jul; 18(7):1001-8. PubMed ID: 3136022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermolecular disulfide bonding in IgM: effects of replacing cysteine residues in the mu heavy chain.
    Davis AC; Roux KH; Pursey J; Shulman MJ
    EMBO J; 1989 Sep; 8(9):2519-26. PubMed ID: 2511005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and functional analysis of J chain-deficient IgM.
    Wiersma EJ; Collins C; Fazel S; Shulman MJ
    J Immunol; 1998 Jun; 160(12):5979-89. PubMed ID: 9637512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assembly of IgM. Role of disulfide bonding and noncovalent interactions.
    Wiersma EJ; Shulman MJ
    J Immunol; 1995 May; 154(10):5265-72. PubMed ID: 7730630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of IgM structures involved in J chain incorporation.
    Wiersma EJ; Chen F; Bazin R; Collins C; Painter RH; Lemieux R; Shulman MJ
    J Immunol; 1997 Feb; 158(4):1719-26. PubMed ID: 9029108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural requirements for IgM assembly and cytolytic activity. Effects of mutations in the oligosaccharide acceptor site at Asn402.
    Muraoka S; Shulman MJ
    J Immunol; 1989 Jan; 142(2):695-701. PubMed ID: 2911015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The biological effects of IgM hexamer formation.
    Randall TD; King LB; Corley RB
    Eur J Immunol; 1990 Sep; 20(9):1971-9. PubMed ID: 2120070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations of the mouse mu H chain which prevent polymer assembly.
    Davis AC; Collins C; Yoshimura MI; D'Agostaro G; Shulman MJ
    J Immunol; 1989 Aug; 143(4):1352-7. PubMed ID: 2501393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay of J chain and disulfide bonding in assembly of polymeric IgM.
    Fazel S; Wiersma EJ; Shulman MJ
    Int Immunol; 1997 Aug; 9(8):1149-58. PubMed ID: 9263012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell surface immunoglobulin. XVI. Polypeptide chain structure of mouse IgM and IgD-like molecule.
    Melcher U; Uhr JW
    J Immunol; 1976 Feb; 116(2):409-15. PubMed ID: 814162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C1q binding properties of monomer and polymer forms of mouse IgM mu-chain variants. Pro544Gly and Pro434Ala.
    Taylor B; Wright JF; Arya S; Isenman DE; Shulman MJ; Painter RH
    J Immunol; 1994 Dec; 153(11):5303-13. PubMed ID: 7963582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the IgM and IgA secretory tailpieces on polymerization and secretion of IgM and IgG.
    Sørensen V; Rasmussen IB; Norderhaug L; Natvig I; Michaelsen TE; Sandlie I
    J Immunol; 1996 Apr; 156(8):2858-65. PubMed ID: 8609405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late events in assembly determine the polymeric structure and biological activity of secretory IgM.
    Brewer JW; Corley RB
    Mol Immunol; 1997 Mar; 34(4):323-31. PubMed ID: 9244345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A region of the immunoglobulin-mu heavy chain necessary for forming pentameric IgM.
    Baker MD; Wu GE; Toone WM; Murialdo H; Davis AC; Shulman MJ
    J Immunol; 1986 Sep; 137(5):1724-8. PubMed ID: 3091689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human J-chain: fix the protein aggregations and yield maximize.
    Redwan el-RM; Matar SM; Serour IA
    Hum Antibodies; 2006; 15(3):95-102. PubMed ID: 17065740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping of amino acid residues in the C mu 3 domain of mouse IgM important in macromolecular assembly and complement-dependent cytolysis.
    Arya S; Chen F; Spycher S; Isenman DE; Shulman MJ; Painter RH
    J Immunol; 1994 Feb; 152(3):1206-12. PubMed ID: 8301125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgA:IgM and IgA:IgA hybrid hybridomas secrete heteropolymeric immunoglobulins that are polyvalent and bispecific.
    Urnovitz HB; Chang Y; Scott M; Fleischman J; Lynch RG
    J Immunol; 1988 Jan; 140(2):558-63. PubMed ID: 3335782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin production by lymphocyte hybridomas.
    Köhler G; Hengartner H; Shulman MJ
    Eur J Immunol; 1978 Feb; 8(2):82-8. PubMed ID: 95956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficiency of cysteine-mediated intracellular retention determines the differential fate of secretory IgA and IgM in B and plasma cells.
    Guenzi S; Fra AM; Sparvoli A; Bet P; Rocco M; Sitia R
    Eur J Immunol; 1994 Oct; 24(10):2477-82. PubMed ID: 7925577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naturally-ocurring low molecular weight IgM in patients with rheumatoid arthritis, systemic lupus erythematosus, and macroglobulinemia. II. Structural studies and comparison of some physicochemical properties of reduced and alkylated IgM, and low molecular weight IgM.
    McDougal JS; Harisdangkul V; Christian CL
    J Immunol; 1975 Jul; 115(1):223-9. PubMed ID: 807625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.